March 22, 2022
Drug Checking Report (Q1 2022): Philadelphia, Pennsylvania, USA
Summary and Key Findings:
  • 36 samples were reported between January and February 2022
  • Most “heroin” samples contained fentanyl cut with xylazine
  • Fentanyl combinations with methamphetamine and cocaine were observed in this sample set, however, not commonly
  • Cocaine samples were not adulterated in this sample set*
  • para-Fluorofentanyl continues increasing in prevalence, being identified as the primary opioid in some “heroin” samples
  • A counterfeit tablet was found to contain an NPS benzodiazepine
Download the Report